It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through ...

The left-hander, who made just two starts after landing a big contract in free agency, was cleared to play catch for the ...

On Thursday, May 15, House T&I held a hearing to discuss the progress on the implementation of different measures from the ...